Enzo Biochem
About: Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.
Employees: 136
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
200% more funds holding in top 10
Funds holding in top 10: 1 [Q3] → 3 (+2) [Q4]
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
22% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 9
2% more funds holding
Funds holding: 43 [Q3] → 44 (+1) [Q4]
1.69% more ownership
Funds ownership: 24.58% [Q3] → 26.27% (+1.69%) [Q4]
31% less capital invested
Capital invested by funds: $14.2M [Q3] → $9.8M (-$4.37M) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for ENZ.
Financial journalist opinion









